Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

Novo Nordisk sees solid Q1 results, major GLP-1 growth potential, and limited downside despite guidance cut and rising risks.

Ozempic, a drug known for its physical health benefits, is now gaining recognition for its effectiveness in treating ...

Health Canada has issued a recall for a lot of Ozempic after discovering that some units may have cracked glass in the medication packaging, which could lead to contamination or injury if used. The ...

While the North Chicago, Illinois-based healthcare giant estimated its adjusted diluted earnings per share for Q3 could reach $1.28 - $1.32 compared to $1.33 in the consensus, its full-year outlook ...